Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program
Journal of Thrombosis and Haemostasis2022Vol. 20(7), pp. 1576–1588
Citations Over TimeTop 10% of 2022 papers
Pamela A. Christopherson, Sandra L. Haberichter, Veronica H. Flood, Crystal L. Perry, Brooke Sadler, Daniel B. Bellissimo, Jorge Di Paola, Robert R. Montgomery, Thomas C. Abshire, Hartmut Weiler, David Lillicrap, Paula James, James S. O’Donnell, Christopher J. Ng, Carolyn M. Bennett, Robert F. Sidonio, M. Manco‐Johnson, Janna M. Journeycake, Ayesha Zia, Jeanne M. Lusher, Madhvi Rajpurkar, Amy D. Shapiro, Steven R. Lentz, M. John Gill, Cindy Leissinger, Margaret V. Ragni, Michael D. Tarantino, Jonathan Roberts, Jeffrey D. Hord, John J. Strouse, Alice Ma, Leonard A. Valentino, Lisa Boggio, Anjali Sharathkumar, Ralph A. Gruppo, Bryce A. Kerlin, R. KULKARNI, D Green, Keith Hoots, Deborah Brown, Donald H. Mahoney, Liesl Mathias, Adees Wirtan Sarkees Bedros, Carol Diamond, Anne T. Neff, Donna DiMichele, Patricia J. Giardina, Alan Cohen, Michael J. Paidas, Eric Werner, Atsuko Matsunaga, Frank Shafer, Barbara A. Konkle, Adam Cuker, Peter A. Kouides, Dagmar Stein
Related Papers
- → von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy(2013)163 cited
- → von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy(2013)72 cited
- → Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome(2018)11 cited
- European Clinical, Laboratory and Molecular (2020 ECLM) Diagnostic Work-Up and Classification of Von Willebrand Disease from the Perspectives of Clinicians and Scientists(2019)
- → Functional Assessment of VWD Type 2N Variants Using Mammalian Cell Displayed Surface-Tethered Von Willebrand Factor(2023)